Pharmamarketeer

Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants

Moderna

The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.

Medhc-fases-banner
Advertentie(s)